Samuel Ow

7PUBLICATIONS
42CO-AUTHORS
Medical devicesCancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 05, 2025
Augmenting Large Language Models With National Comprehensive Cancer Network Guidelines for Improved and Standardized Adjuvant Therapy Recommendations in Postoperative Breast Cancer Cases.

Serene Si Ning Goh, Ragunathan Mariappan, Grace Soo Woon Tan

|Jul 24, 2025
Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial.

Natalie Y L Ngoi, Chel Hun Choi, Junxian Zhu

|Jul 12, 2025
Supraclavicular Lymph Node Dissection in Breast Cancer with Synchronous Supraclavicular Metastases: A Systematic Review and Network Meta-Analysis.

George Shiyao He, Jolene Li Ling Chia, Emmeline Elaine Cua-De Los Santos

|Apr 01, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast Cancer.

Joline S J Lim, Andrea L A Wong, Samuel G W Ow

|Jun 24, 2020
Nurse-Led Vital Signs Monitoring Can Safely Identify Low-Risk Hematology-Oncology Patients For De-Escalation.

Sai Meng Tham, Sharmilla Kasinathan, Pak Ling Lui

|Jun 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers.

Soo-Chin Lee, Noriko Shimasaki, Joline S J Lim

Pageof 2

Frequent Collaborators

2 joint publications

Kritika Yadav

2 joint publications

Wei Peng Yong

2 joint publications

Serene Si Ning Goh

2 joint publications

Raghav Sundar